Background: Iron supplementation is essential in managing iron deficiency anemia, but the stability of iron compounds significantly affects their efficacy. Ferric pyrophosphate (FePP), though commonly used, is prone to oxidative degradation. Microencapsulation with stabilizers such as lecithin and maltodextrin may improve its oxidative stability, yet comparative data between coated and uncoated FePP are limited.
Methods: This study compared the oxidative stability of uncoated FePP and microencapsulated SunActive™ Fe (coated with lecithin and maltodextrin). Samples were exposed to hydrogen peroxide (0.1%, 1%, 2%, and 3%) to induce oxidative stress. The reduction of ferric (Fe³⁺) to ferrous (Fe²⁺) iron was quantified using a colorimetric assay based on Fe²⁺–1,10-phenanthroline complex formation, measured spectrophotometrically at 510 nm across multiple time points up to 15 minutes.
Results: Uncoated FePP showed a rapid, concentration-dependent increase in Fe²⁺ levels, indicating high oxidative reactivity. In contrast, encapsulated SunActive™ Fe exhibited significantly lower Fe³⁺ → Fe²⁺ conversion across all peroxide concentrations and time points (p < 0.005). The reduced Fe²⁺ formation in the coated sample confirms that microencapsulation effectively protects ferric centers from peroxide-induced reduction.
Discussion: Microencapsulation with lecithin and maltodextrin enhances the oxidative stability of ferric pyrophosphate by restricting peroxide access and reducing redox cycling. These findings highlight the potential of encapsulation as a simple, cost-effective strategy to improve the stability, safety, and shelf life of iron supplements, particularly under oxidative storage conditions.
If you have any questions about submitting your review, please email us at [email protected].